Cognitive Appraisal, Treatment Outcomes, and Quality of Life Over Time in Persons Newly Diagnosed With Cancer

2.50
Hdl Handle:
http://hdl.handle.net/10755/150821
Type:
Presentation
Title:
Cognitive Appraisal, Treatment Outcomes, and Quality of Life Over Time in Persons Newly Diagnosed With Cancer
Abstract:
Cognitive Appraisal, Treatment Outcomes, and Quality of Life Over Time in Persons Newly Diagnosed With Cancer
Conference Sponsor:Sigma Theta Tau International
Conference Year:2005
Author:Kessler, Theresa A., PhD, APRN, BC
P.I. Institution Name:Valparaiso University
Title:Associate Professor
Medical outcomes, such as disease free survival, mortality, symptom management, and cancer relapse rates, have typically been used to evaluate treatment and recovery from cancer. With more successful cancer treatment, measurement outcomes focusing on quantity are becoming insufficient. Comprehensive outcome measurement must evaluate the experience as perceived by the individual living with cancer. Critical to the measurement of this personal experience is the evaluation of an individual's cognitive appraisal and quality of life (QOL). QOL is perceived uniquely by individuals and is an issue of increasing importance to those living with cancer. According to the transactional model of stress and coping, what an individual cognitively appraises about the cancer experience influences QOL and the resulting adaptation to the potentially stressful event. The purpose of this study was to assess cognitive appraisals, treatment outcomes, and the impact of these variables on quality of life over time for individuals facing a new diagnosis of cancer. Data were collected over one year using a repeated measures design. Instruments included: a researcher developed tool to measure treatment related variables, the Cognitive Appraisal of Health Scale, and the Quality of Life Index Cancer Version û III. Subjects were female (71%), married (79%), worked (50%), high school graduates (85%), and aged 23 - 78 years (M = 62). The top cancer diagnoses were breast (39%) and lung (18%); the majority (43%) was treated with chemotherapy initially. Seven variables from the model explained 84% of the variance in QOL scores at initial diagnosis, F(8, 57) = 36.42, p
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleCognitive Appraisal, Treatment Outcomes, and Quality of Life Over Time in Persons Newly Diagnosed With Canceren_GB
dc.identifier.urihttp://hdl.handle.net/10755/150821-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Cognitive Appraisal, Treatment Outcomes, and Quality of Life Over Time in Persons Newly Diagnosed With Cancer</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2005</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Kessler, Theresa A., PhD, APRN, BC</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Valparaiso University</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Associate Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">terry.kessler@valpo.edu</td></tr><tr><td colspan="2" class="item-abstract">Medical outcomes, such as disease free survival, mortality, symptom management, and cancer relapse rates, have typically been used to evaluate treatment and recovery from cancer. With more successful cancer treatment, measurement outcomes focusing on quantity are becoming insufficient. Comprehensive outcome measurement must evaluate the experience as perceived by the individual living with cancer. Critical to the measurement of this personal experience is the evaluation of an individual's cognitive appraisal and quality of life (QOL). QOL is perceived uniquely by individuals and is an issue of increasing importance to those living with cancer. According to the transactional model of stress and coping, what an individual cognitively appraises about the cancer experience influences QOL and the resulting adaptation to the potentially stressful event. The purpose of this study was to assess cognitive appraisals, treatment outcomes, and the impact of these variables on quality of life over time for individuals facing a new diagnosis of cancer. Data were collected over one year using a repeated measures design. Instruments included: a researcher developed tool to measure treatment related variables, the Cognitive Appraisal of Health Scale, and the Quality of Life Index Cancer Version &ucirc; III. Subjects were female (71%), married (79%), worked (50%), high school graduates (85%), and aged 23 - 78 years (M = 62). The top cancer diagnoses were breast (39%) and lung (18%); the majority (43%) was treated with chemotherapy initially. Seven variables from the model explained 84% of the variance in QOL scores at initial diagnosis, F(8, 57) = 36.42, p</td></tr></table>en_GB
dc.date.available2011-10-26T10:43:47Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T10:43:47Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.